Accrued Expenses and Other Current Liabilities

6 Months Ended

Jun. 30, 2025

10. Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):


	June 30, 2025		December 31, 2024
Product revenue allowances	$	5,204	$	849
Accrued clinical study and trial costs		21,203		23,869
Accrued selling, general, and administrative costs		5,582		4,258
Accrued compensation and related costs		14,505		14,477
Accrued professional fees		—		385
Accrued milestone costs		5,000		10,600
Accrued royalty interest expense		18,954		4,930
Other		618		421
Total accrued expenses and other current liabilities	$	71,066	$	59,789